Lens power fine tuning device
Latest Novartis AG Patents:
- Antibody molecules to LAG-3 and uses thereof
- Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Pyrazolopyridine derivatives and uses thereof
- Methods for improving the efficacy and expansion of immune cells
Description
Claims
The ornamental design for a lens power fine tuning device, as shown and described.
Referenced Cited
U.S. Patent Documents
Patent History
Patent number: D608448
Type: Grant
Filed: Oct 31, 2008
Date of Patent: Jan 19, 2010
Assignee: Novartis AG (Basel)
Inventors: Joseph Rappon (Alpharetta, GA), Peter Bergenske (Alpharetta, GA), Timothy Andrew Giles (Roswell, GA)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Robert Ambrose
Application Number: 29/327,138
Type: Grant
Filed: Oct 31, 2008
Date of Patent: Jan 19, 2010
Assignee: Novartis AG (Basel)
Inventors: Joseph Rappon (Alpharetta, GA), Peter Bergenske (Alpharetta, GA), Timothy Andrew Giles (Roswell, GA)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Robert Ambrose
Application Number: 29/327,138
Classifications
Current U.S. Class:
Ophthalmic (44) (D24/172)